The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Mechanism mediating oligomeric Aβ clearance by naïve primary microglia
Abstract
The accumulation of soluble oligomeric amyloid-β peptide (oAβ) proceeds the formation of senile plaques and contributes to synaptic and memory deficits in Alzheimer's disease (AD). The mechanism of mediating microglial oAβ clearance remains unclear and thought to occur via scavenger receptors (SRs) in microglia. SRs respond to their ligands in a subtype-specific manner. Therefore, we sought to identify the specific subtypes of SRs that mediate oAβ internalization and proteases that degrade oAβ species in naïve primary microglia. The component of oAβ species were characterized by western blot analysis, analytical ultracentrifugation analysis, and atomic force microscopy. The oAβ species remained soluble in the medium and microglial lysates during incubation at 37 °C. SR-A, but not CD36, mediated oAβ internalization in microglia as suggested by the use of subtype-specific neutralizing antibodies and small interfering RNAs (siRNAs). Immunoprecipitation analysis showed that oAβ interacted with SR-A on the plasma membrane. After internalization, over 40% of oAβ vesicles were trafficked toward lysosomes and degraded by cysteine proteases, including cathepsin B. The inhibitors of proteasome, neprilysin, matrix metalloproteinases, and insulin degrading enzyme failed to protect internalized oAβ from degradation. Our study suggests that SR-A and lysosomal cathepsin B are critical in microglial oAβ clearance, providing insight into how microglia are involved in the clearance of oAβ and…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Both neurons and glia can clear extracellular Ab through endocytosis for subsequent lysosomal degradation or secretion of amyloid-degrading enzymes for extracellular clearance.
“We and others have shown that both neurons and glia can clear extracellular Ab through endocytosis for subsequent lysosomal degradation or secretion of amyloiddegrading enzymes for extracellular clearance (4,7).”
From Differential protective effects of connective tissue growth factor against Aβ neurotoxicity on neurons and glia (2017) · cites this paper as [7]
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 3×
“AUC analysis suggested that the major species of oAβ consisted of dimers, hexamers, and dodecamers, which have been shown to cause synaptic impairments both in vivo and in vitro (Lesne et al., 2006; Shankar et al., 2008).”
InfluentialRetractedSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis
Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015
ApoE Promotes the Proteolytic Degradation of Aβ
Jiang, Q., Lee, C. Y. D., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.010 · Cited by 876
Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727
Scavenger Receptors in Atherosclerosis: Beyond Lipid Uptake
Moore, K. J., & Freeman, M. W. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000229218.97976.43 · Cited by 562
Self-Assembly of Aβ 1 - 42 into Globular Neurotoxins
Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., et al. (2003) · Biochemistry · doi:10.1021/bi030029q · Cited by 522
Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo
Klyubin, I., Walsh, D. M., Lemere, C. A., Cullen, W. K., Shankar, G. M., Betts, V., Spooner, E. T., Jiang, L., Anwyl, R., Selkoe, D. J., et al. (2005) · Nature Medicine · doi:10.1038/nm1234 · Cited by 489
Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide
Hu, X., Crick, S. L., Bu, G., Frieden, C., Pappu, R. V., & Lee, J.-M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911281106 · Cited by 426
The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes
Graves, A. R., Curran, P. K., Smith, C. L., & Mindell, J. A. (2008) · Nature · doi:10.1038/nature06907 · Cited by 399
Coraci, I. S., Husemann, J., Berman, J. W., Hulette, C., Dufour, J. H., Campanella, G. K., Luster, A. D., Silverstein, S. C., & El Khoury, J. B. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64354-4 · Cited by 398
Microglial senescence: does the brain's immune system have an expiration date?
Streit, W. J. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.07.001 · Cited by 397
Activation of Microglia Acidifies Lysosomes and Leads to Degradation of Alzheimer Amyloid Fibrils
Majumdar, A., Cruz, D., Asamoah, N., Buxbaum, A., Sohar, I., Lobel, P., & Maxfield, F. R. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-10-0975 · Cited by 271
Sun, B., Zhou, Y., Halabisky, B., Lo, I., Cho, S.-H., Mueller-Steiner, S., Devidze, N., Wang, X., Grubb, A., & Gan, L. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.001 · Cited by 231
IL-4-Induced Selective Clearance of Oligomeric β-Amyloid Peptide1–42 by Rat Primary Type 2 Microglia
Shimizu, E., Kawahara, K., Kajizono, M., Sawada, M., & Nakayama, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6503 · Cited by 143
Flagged first, then by citations
Research works printed but not linked: 32
- Barrachina, 2006, Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease, Neuropathol. Appl. Neurobiol., 32, 505, 10.1111/j.1365-2990.2006.00756.x · DOI · Paper page
- Blennow, 2006, Alzheimer's disease, Lancet, 368, 387, 10.1016/S0140-6736(06)69113-7 · DOI · Paper page
- Brown, 2006, Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation, Biophys. J., 90, 4651, 10.1529/biophysj.106.081372 · DOI
- Chou, 2005, Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution, Biophys. J., 88, 455, 10.1529/biophysj.104.046813 · DOI · Paper page
- Chung, 1999, Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells, J. Biol. Chem., 274, 32301, 10.1074/jbc.274.45.32301 · DOI · Paper page
- Cooper, 2006, Clathrin-mediated endocytosis and lysosomal cleavage of hepatitis B virus capsid-like core particles, J. Biol. Chem., 281, 16563, 10.1074/jbc.M601418200 · DOI
- Feng, 2007, Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity, Oncogene, 26, 3431, 10.1038/sj.onc.1210129 · DOI
- Huang, 2009, Enlargement of Abeta aggregates through chemokine-dependent microglial clustering, Neurosci. Res., 63, 280, 10.1016/j.neures.2009.01.001 · DOI
- Husemann, 2002, Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system, Glia, 40, 195, 10.1002/glia.10148 · DOI
- Lee, 2008, Clearance and deposition of extracellular alpha-synuclein aggregates in microglia, Biochem. Biophys. Res. Commun., 372, 423, 10.1016/j.bbrc.2008.05.045 · DOI · Paper page
- Longva, 2002, Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies, J. Cell Biol., 156, 843, 10.1083/jcb.200106056 · DOI
- Mandrekar, 2009, Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis, J. Neurosci., 29, 4252, 10.1523/JNEUROSCI.5572-08.2009 · DOI · Paper page
- Marques, 2004, Ubiquitin-dependent lysosomal degradation of the HNE-modified proteins in lens epithelial cells, FASEB J., 18, 1424, 10.1096/fj.04-1743fje · DOI
- Meilandt, 2009, Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice, J. Neurosci., 29, 1977, 10.1523/JNEUROSCI.2984-08.2009 · DOI
- Mueller-Steiner, 2006, Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease, Neuron, 51, 703, 10.1016/j.neuron.2006.07.027 · DOI
- Nakamura, 1989, Lysosome instability in aged rat brain, Neurosci. Lett., 97, 215, 10.1016/0304-3940(89)90166-3 · DOI
- Nakanishi, 2009, Microglia-aging: roles of microglial lysosome- and mitochondria-derived reactive oxygen species in brain aging, Behav. Brain Res., 201, 1, 10.1016/j.bbr.2009.02.001 · DOI
- Nishi, 2002, The vacuolar (H+)-ATPases—nature's most versatile proton pumps, Nat. Rev. Mol. Cell Biol., 3, 94, 10.1038/nrm729 · DOI · Paper page
- Ono, 2009, Structure–neurotoxicity relationships of amyloid beta-protein oligomers, Proc. Natl Acad. Sci. USA, 106, 14745, 10.1073/pnas.0905127106 · DOI
- Paresce, 1996, Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor, Neuron, 17, 553, 10.1016/S0896-6273(00)80187-7 · DOI · Paper page
- Roychaudhuri, 2009, Amyloid beta-protein assembly and Alzheimer disease, J. Biol. Chem., 284, 4749, 10.1074/jbc.R800036200 · DOI
- Schuck, 2000, Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling, Biophys. J., 78, 1606, 10.1016/S0006-3495(00)76713-0 · DOI
- Selkoe, 2001, Clearing the brain's amyloid cobwebs, Neuron, 32, 177, 10.1016/S0896-6273(01)00475-5 · DOI · Paper page
- Shie, 2005, Microglia lacking E prostanoid receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity, Am. J. Pathol., 166, 1163, 10.1016/S0002-9440(10)62336-X · DOI
- Sondag, 2009, Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia, J. Neuroinflammation, 6, 1, 10.1186/1742-2094-6-1 · DOI · Paper page
- Streit, 2009, Life and death of microglia, J. Neuroimmune Pharmacol., 4, 371, 10.1007/s11481-009-9163-5 · DOI · Paper page
- Tahara, 2006, Role of toll-like receptor signalling in Abeta uptake and clearance, Brain, 129, 3006, 10.1093/brain/awl249 · DOI · Paper page
- Townsend, 2006, Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers, J. Physiol., 572, 477, 10.1113/jphysiol.2005.103754 · DOI · Paper page
- Wang, 1995, Degradation of apolipoprotein B in cultured rat hepatocytes occurs in a post-endoplasmic reticulum compartment, J. Biol. Chem., 270, 24924, 10.1074/jbc.270.42.24924 · DOI
- Wang, 2006, Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives, Drug Discov. Today, 11, 931, 10.1016/j.drudis.2006.08.004 · DOI
- Yamasaki, 2007, Involvement of lysosomal storage-induced p38 MAP kinase activation in the overproduction of nitric oxide by microglia in cathepsin D-deficient mice, Mol. Cell. Neurosci., 35, 573, 10.1016/j.mcn.2007.05.002 · DOI
- Yang, 1998, Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1–42 pathogenesis, J. Neurosci. Res., 52, 691, 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3 · DOI
Cited by
Sorted by citations
Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
Condello, C., Yuan, P., Schain, A., & Grutzendler, J. (2015) · Nature Communications · doi:10.1038/ncomms7176 · Cited by 718
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583
Mechanisms of Aβ Clearance and Degradation by Glial Cells
Ries, M., & Sastre, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00160 · Cited by 527
“…also involved in Aβ degradation, but whose relevance depends on the degree of Aβ pathology, are plasminogen activators and angiotensin-converting enzyme (ACE) (Hu et al., 2001), which are more effective for aggregated Aβ rather than regulating steady-state Aβ levels (Saido and Leissring, 2012).”
BackgroundCathepsin B as a cancer target
Gondi, C. S., & Rao, J. S. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.740461 · Cited by 399
Cai, Y., Liu, J., Wang, B., Sun, M., & Yang, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.856376 · Cited by 351
Doens, D., & Fernández, P. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-48 · Cited by 348
Aβ-degrading enzymes: potential for treatment of Alzheimer disease
Miners, J. S., Barua, N., Kehoe, P. G., Gill, S., & Love, S. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182345e46 · Cited by 265
Microglial Aβ Receptors in Alzheimer’s Disease
Yu, Y., & Ye, R. D. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0101-6 · Cited by 247
Role of TGFβ signaling in the pathogenesis of Alzheimer’s disease
von Bernhardi, R., Cornejo, F., Parada, G. E., & Eugenín, J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00426 · Cited by 149
Kamphuis, W., Kooijman, L., Orre, M., Stassen, O., Pekny, M., & Hol, E. M. (2015) · Glia · doi:10.1002/glia.22800 · Cited by 155
Natural Products as a Potential Modulator of Microglial Polarization in Neurodegenerative Diseases
Jin, X., Liu, M.-Y., Zhang, D.-F., Zhong, X., Du, K., Qian, P., Gao, H., & Wei, M.-J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104253 · Cited by 109
Shibuya, Y., Chang, C. C. Y., Huang, L.-H., Bryleva, E. Y., & Chang, T.-Y. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2567-14.2014 · Cited by 108
“Microglia de- grade oligomeric A within the late endosomes/lysosomes (LE/ LS) (Yang et al., 2011).”
BackgroundInfluentialMarlatt, M. W., Bauer, J., Aronica, E., van Haastert, E. S., Hoozemans, J. J. M., Joels, M., & Lucassen, P. J. (2014) · Neural Plasticity · doi:10.1155/2014/693851 · Cited by 83
Misfolded Truncated Protein τ Induces Innate Immune Response via MAPK Pathway
Kovac, A., Zilka, N., Kazmerova, Z., Cente, M., Zilkova, M., & Novak, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100216 · Cited by 75
Cornejo, F., Vruwink, M., Metz, C., Muñoz, P., Salgado, N., Poblete, J., Andrés, M. E., Eugenín, J., & von Bernhardi, R. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.12.007 · Cited by 59
Mathur, R., Ince, P. G., Minett, T., Garwood, C. J., Shaw, P. J., Matthews, F. E., Brayne, C., Simpson, J. E., Wharton, S. B., & on behalf of the MRC Cognitive Function and Ageing Neuropathology Study Group (2015) · PLOS ONE · doi:10.1371/journal.pone.0118463 · Cited by 52
Scheiner, M., Dolles, D., Gunesch, S., Hoffmann, M., Nabissi, M., Marinelli, O., Naldi, M., Bartolini, M., Petralla, S., Poeta, E., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00623 · Cited by 49
Yang, C.-N., Wu, M.-F., Liu, C.-C., Jung, W.-H., Chang, Y.-C., Lee, W.-P., Shiao, Y.-J., Wu, C.-L., Liou, H.-H., Lin, S.-K., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx278 · Cited by 27
Self-citation
Metadata
- Authors
- Yang, C.-N., Shiao, Y.-J., Shie, F.-S., Guo, B.-S., Chen, P.-H., Cho, C.-Y., Chen, Y.-J., Huang, F.-L., & Tsay, H.-J.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 42
- Issue
- 3
- Pages
- 221-230
- ISSN
- 0969-9961
- Cited by
- 117
- References
- 19
- Language
- en
- Funders
- NSC (94-2321-B-010-006, and NSC99-2320-B-010-012)
- Brain Research Center ((99ACB6-2))
- Ministry of Education-Aim for the Top University Plan (98A-C-D105)
- Mackey memorial hospital (MMH-YM-9903)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review